Search company, investor...

Predict your next investment

Private Equity
consonancecapital.com

Investments

14

Portfolio Exits

5

Funds

3

About Consonance Capital

Consonance Capital is a healthcare investment firm that invests broadly across the healthcare landscape. Private investments, which include growth equity, leveraged buyouts, and recapitalizations, are made under the direction of Consonance Capital Partners, a private equity manager led by Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle. Public investments are made under the direction of Consonance Capital Management, a long/short public equity manager. Consonance Capital was established in 2005 and is located in New York City.

Headquarters Location

1370 Avenue of the Americas 33rd Floor

New York, New York, 10019,

United States

212-660-8060

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Consonance Capital News

Consonance Capital makes partner promotion

May 16, 2023

Consonance Capital makes partner promotion Submitted 16/05/2023 - 11:27am Consonance Capital Partners (CCP), a US healthcare-focused private equity firm, has promoted Sapna T Jethwa, who joined the business in 2012 and has been involved in the firm's investments in Enclara Health, Turn-Key Health, and Psychiatric Medical Care, to partner – business development. Over the past several years, Jethwa has led the firm’s business development efforts and driven CCP’s thematic sourcing model. Prior to joining CCP, she held positions at Bessemer Venture Partners, in JP Morgan’s Healthcare Investment Banking Group, and at The Monitor Group.  Jethwa holds an MBA from The Wharton School and is a graduate of the Healthcare Management Program. Additionally, she holds a BAS in Biomedical Science from the University of Pennsylvania, School of Engineering & Applied Sciences and a BS in Economics with a concentration in Finance from the Wharton School. Like this article? Sign up to our free newsletter Author Profile Related Topics Intelligence People

Consonance Capital Investments

14 Investments

Consonance Capital has made 14 investments. Their latest investment was in Calviri as part of their Unattributed - III on November 11, 2021.

CBI Logo

Consonance Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/9/2021

Unattributed - III

Calviri

$11.08M

Yes

2

8/26/2021

Seed VC

Sugar

$2.5M

Yes

12

5/5/2021

Seed VC

Lami

$1.8M

Yes

16

3/30/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

5/26/2020

PIPE

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/9/2021

8/26/2021

5/5/2021

3/30/2021

5/26/2020

Round

Unattributed - III

Seed VC

Seed VC

Seed VC - II

PIPE

Company

Calviri

Sugar

Lami

Subscribe to see more

Subscribe to see more

Amount

$11.08M

$2.5M

$1.8M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

12

16

10

10

Consonance Capital Portfolio Exits

5 Portfolio Exits

Consonance Capital has 5 portfolio exits. Their latest portfolio exit was Ladenburg Thalmann Financial Services on February 14, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/14/2020

Take Private

$99M

5

12/16/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/30/2017

Acq - Fin - II

Subscribe to see more

$99M

Subscribe to see more

10

7/9/2010

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

6/12/2006

IPO

Subscribe to see more

$99M

Subscribe to see more

0

Date

2/14/2020

12/16/2019

5/30/2017

7/9/2010

6/12/2006

Exit

Take Private

Acquired

Acq - Fin - II

Acq - Fin

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

0

Consonance Capital Acquisitions

6 Acquisitions

Consonance Capital acquired 6 companies. Their latest acquisition was Embark Behavioral Health on September 01, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/1/2022

$99M

Acq - Fin

3

5/7/2015

Series C

Subscribe to see more

$99M

$99M

Subscribe to see more

10

8/18/2014

Subscribe to see more

$99M

Subscribe to see more

10

8/18/2014

Subscribe to see more

$99M

Subscribe to see more

10

5/29/2014

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/1/2022

5/7/2015

8/18/2014

8/18/2014

5/29/2014

Investment Stage

Series C

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$99M

Note

Acq - Fin

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

Consonance Capital Fund History

3 Fund Histories

Consonance Capital has 3 funds, including Consonance Private Equity II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/28/2020

Consonance Private Equity II

Industry Focused

Open

$856M

3

4/24/2020

Consonance Private Equity PV II

$99M

10

7/21/2014

Consonance Capital Healthcare Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

4/28/2020

4/24/2020

7/21/2014

Fund

Consonance Private Equity II

Consonance Private Equity PV II

Consonance Capital Healthcare Fund

Fund Type

Industry Focused

Subscribe to see more

Status

Open

Subscribe to see more

Amount

$856M

$99M

$99M

Sources

3

10

10

Consonance Capital Team

4 Team Members

Consonance Capital has 4 team members, including current Founder, Chief Executive Officer, Mitchell Blutt.

Name

Work History

Title

Status

Mitchell Blutt

Founder, Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Mitchell Blutt

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.